11/15
Coronavirus
What the U.S. economy will look like after the pandemic
It has been a long pandemic, from which the country is still emerging, but the U.S.
Penn study details robust T-cell response to mRNA COVID-19 vaccines
The results underline the importance of a second dose and include implications for booster shots.
Engineers create faster and cheaper COVID-19 testing with pencil lead
A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.
A how-to guide for Gateway testing
Penn Today provides details on the Penn Cares testing program and how undergraduate and graduate students can fulfill their Gateway testing requirements.
Remote learning affected high schoolers’ social, emotional health
Research from Angela Duckworth and colleagues found that teenagers who attended school virtually fared worse than classmates who went in person, results that held even when accounting for variables like gender, race, and socioeconomic status.
When trust in science fosters pseudoscience
A study co-authored by PIK Professor Dolores Albarracín finds that people who trust science are more likely to believe and disseminate false claims containing scientific references than people who do not trust science.
Community concerns about the COVID-19 vaccine tracked by Twitter
A study of vaccine-related Twitter posts reveals significant differences in concerns people have when broken down by age, race, population density, and religious beliefs.
A COVID vaccine for kids
Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential.
The long view on COVID-19 vaccine safety and efficacy
Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines.
Vaccine conversations go door-to-door
Canvasser with the West Philadelphia Vaccine Street Team Pilot Program go door to door to dispel misinformation and show their neighbors that vaccination is safe, by example.
In the News
Column: How a blunder by a respected medical journal is fueling an anti-vaccine lie
Jeffrey S. Morris of the Perelman School of Medicine says that even with a 100% effective vaccine, there would have been high levels of morbidity and mortality from COVID-19 in 2021.
FULL STORY →
After four years with COVID-19, the U.S. is settling into a new approach to respiratory virus season
Kathleen Hall Jamieson of the Annenberg Public Policy Center says that the sense of urgency around vaccination has faded as attention on respiratory viruses wanes.
FULL STORY →
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Paul Offit looks back on COVID-19, misinformation, and how public health lost the public’s trust in new book
“Tell Me When It’s Over,” a new book by Paul Offit of the Perelman School of Medicine, chronicles the initial years of the COVID-19 pandemic and the mishaps of public health agencies. Recent surveys by the Annenberg Public Policy Center find that mistrust of vaccines has continued to grow through last fall.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →